Herbas VPB

Print
EN | LT
LT - Tulžies rūgšties dariniai kaip FXR/TGR agonistai, ir jų panaudojimo būdai
EN - BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07J 41/00 (2006.01)
C07J 43/00 (2006.01)
A61K 31/575 (2006.01)
A61P 1/16 (2006.01)
C07J 9/00 (2006.01)
C07J 51/00 (2006.01)
European patent
(11) Number of the document 3277286
(13) Kind of document T
(96) European patent application number 16774118.0
Date of filing the European patent application 2016-03-30
(97) Date of publication of the European application 2018-02-07
(45) Date of publication and mention of the grant of the patent 2021-04-21
(46) Date of publication of the claims translation 2021-07-26
PCT application
(86) Number PCT/US2016/025035
Date 2016-03-30
PCT application publication
(87) Number WO 2016/161003
Date 2016-10-06
Priority applications
(30) Number Date Country code
201562140927 P 2015-03-31 US
201662287267 P 2016-01-26 US
Inventors
(72)
WANG, Guoqiang, US
OR, Yat Sun, US
SHEN, Ruichao, US
XING, Xuechao, US
LONG, Jiang, US
DAI, Peng, US
GRANGER, Brett, US
HE, Jing, US
Grantee
(73) Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown, MA 02472, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Tulžies rūgšties dariniai kaip FXR/TGR agonistai, ir jų panaudojimo būdai
  BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
Last renewal fee
Payment date Validity (years) Amount
2023-03-02 8 185.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2024-03-30